Portfolio company
AmacaThera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops injectable hydrogel drug delivery platforms for pharmaceutical partners to provide sustained post-surgical pain management and localised therapeutic release.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Allay Therapeutics
The company develops long-acting localized pain management technology for patients recovering from surgery.
PNAS Therapeutics
This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
PainReform
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
Alessa Therapeutics
This company develops a drug-delivery platform for the localized release of therapies to treat patients with early-stage prostate cancer.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
Medincell
Medincell develops long-acting injectable medicines for pharmaceutical and veterinary partners to improve patient adherence across multiple therapeutic areas.
